SOHM Files Provisional Patent on ABBIE's 'Smart Gene-Editing' That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations Seite 1
09.01.2024 - CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) - via IBN - SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets generic drugs covering numerous treatment ... Seite 1
Source: wallstreet-online.de